Clinical considerations in individuals with α1-antitrypsin PI*SZ genotype.
Ontology highlight
ABSTRACT: α1-Antitrypsin deficiency (AATD), characterised by reduced levels or functionality of α1-antitrypsin (AAT), is a significantly underdiagnosed genetic condition that predisposes individuals to lung and liver disease. Most of the available data on AATD are based on the most common, severe deficiency genotype (PI*ZZ); therefore, treatment and monitoring requirements for individuals with the PI*SZ genotype, which is associated with a less severe AATD, are not as clear. Recent genetic data suggest the PI*SZ genotype may be significantly more prevalent than currently thought, due in part to less frequent identification in the clinic and less frequent reporting in registries. Intravenous AAT therapy, the only specific treatment for patients with AATD, has been shown to slow disease progression in
SUBMITTER: McElvaney GN
PROVIDER: S-EPMC7301289 | biostudies-literature | 2020 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA